
Sunil Healthcare Ltd is Rated Sell by MarketsMOJO
2026-08-02 10:10:38Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 August 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Sunil Healthcare Ltd is Rated Sell
2026-07-21 10:11:16Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 July 2026, providing investors with the most recent and relevant data to assess the stock’s outlook.
Read full news article
Sunil Healthcare Ltd is Rated Sell
2026-07-08 10:11:28Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 08 July 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Sunil Healthcare Ltd is Rated Sell
2026-06-26 10:10:49Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 June 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the company’s current position as of 26 June 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.
Read full news article
Sunil Healthcare Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals
2026-06-15 08:05:33Sunil Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 12 June 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The micro-cap pharmaceutical company’s Mojo Score improved to 31.0, reflecting a nuanced market view amid flat financial performance and ongoing valuation challenges.
Read full news article
Sunil Healthcare Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
2026-06-08 08:10:47Sunil Healthcare Ltd has been downgraded from a Sell to a Strong Sell rating as of 5 June 2026, reflecting deteriorating technical indicators and persistently weak financial fundamentals. The pharmaceutical micro-cap’s current Mojo Score stands at 26.0, underscoring significant concerns across quality, valuation, financial trends, and technicals that have prompted this decisive rating change.
Read full news article
Sunil Healthcare Q4 FY26: Profitability Returns Amid Revenue Headwinds
2026-05-30 23:48:23Sunil Healthcare Limited, India's second-largest manufacturer of empty hard gelatin capsules, reported a remarkable turnaround in profitability for Q4 FY26, posting a net profit of ₹1.52 crores—a dramatic 322.22% surge year-on-year from ₹0.36 crores in Q4 FY25. However, this earnings recovery came against a backdrop of declining revenues, with quarterly sales dropping 6.98% YoY to ₹19.72 crores, raising questions about the sustainability of this profitability rebound. The stock, trading at ₹63.50 with a market capitalisation of ₹67.00 crores, has declined 6.19% following the results announcement, reflecting investor scepticism about the company's growth trajectory.
Read full news article
Sunil Healthcare Ltd is Rated Sell
2026-05-29 10:11:03Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 May 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleBoard Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On 13.08.2026 Pursuant To Regulation 29 Read With Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
31-Jul-2026 | Source : BSESunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Board Meeting scheduled to be held on 13.08.2026 pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 inter alia to consider approve and take on record the Un-Audited Financial Results (both standalone and consolidated) for the 1st quarter of FY 2026-27 ended on June 30 2026.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Jul-2026 | Source : BSECompliance Certificate for the 1st quarter of FY 2026-27 ended 30th June 2026 under Reg. 74(5) of SEBI (DP) regulations
Special Window For Transfer And Dematerialisation (Demat) Of Physical Securities
30-Jun-2026 | Source : BSESpecial window for Transfer and Dematerialisation of Physical Securities
Corporate Actions
13 Aug 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






